Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor

por Eskens, Ferry ALM, Haberkorn, Brigitte
Publicado 2012

Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned

por de Brabander, Justin, Eskens, Ferry A.L.M., Korsse, Susanne E., Dekker, Evelien, Dewint, Pieter, van Leerdam, Monique E., van Eeden, Susanne, Klümpen, Heinz‐Josef
Publicado 2018

First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial

por Levy, Sonja, Verbeek, Wieke H.M., Eskens, Ferry A.L.M., van den Berg, José G., de Groot, Derk Jan A., van Leerdam, Monique E., Tesselaar, Margot E.T.
Publicado 2022

Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial

por Jones, Robin L., Serrano, César, von Mehren, Margaret, George, Suzanne, Heinrich, Michael C., Kang, Yoon-Koo, Schöffski, Patrick, Cassier, Philippe A., Mir, Olivier, Chawla, Sant P., Eskens, Ferry A.L.M., Rutkowski, Piotr, Tap, William D., Zhou, Teresa, Roche, Maria, Bauer, Sebastian
Publicado 2021

A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers

por Diab, Adi, Hamid, Omid, Thompson, John A., Ros, Willeke, Eskens, Ferry A.L.M., Doi, Toshihiko, Hu-Lieskovan, Siwen, Klempner, Samuel J., Ganguly, Bishu, Fleener, Catherine, Wang, Xiao, Joh, Tenshang, Liao, Ken, Salek-Ardakani, Shahram, Taylor, Carrie Turich, Chou, Jeffrey, El-Khoueiry, Anthony B.
Publicado 2022

Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)

por Suker, Mustafa, Nuyttens, Joost J., Eskens, Ferry A.L.M., Haberkorn, Brigitte C.M., Coene, Peter-Paul L.O., van der Harst, Erwin, Bonsing, Bert A., Vahrmeijer, Alexander L., Mieog, J.Sven D., Jan Swijnenburg, Rutger, Roos, Daphne, Koerkamp, B.Groot., van Eijck, Casper H.J.
Publicado 2019

Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study

por de Man, Femke M., Hussaarts, Koen G.A.M., de With, Mirjam, Oomen‐de Hoop, Esther, de Bruijn, Peter, van Halteren, Henk K., van der Burg‐de Graauw, Nicole C.H.P., Eskens, Ferry A.L.M., van Gelder, Teun, van Leeuwen, Roelof W.F., Mathijssen, Ron H.J.
Publicado 2019

CX-072 (pacmilimab), a Probody(®) PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

por Naing, Aung, Thistlethwaite, Fiona, De Vries, Elisabeth G.E., Eskens, Ferry A.L.M., Uboha, Nataliya, Ott, Patrick A., LoRusso, Patricia, Garcia-Corbacho, Javier, Boni, Valentina, Bendell, Johanna, Autio, Karen A., Randhawa, Manreet, Durm, Greg, Gil-Martin, Marta, Stroh, Mark, Hannah, Alison L., Arkenau, Hendrik-Tobias, Spira, Alexander
Publicado 2021